A pathogenetic model for erosive synovitis. Lessons from animal arthritides

Arthritis & Rheumatism

Volumn 19, Issue 2, 1976, Pages 256-266

  Hadler, Nortin M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; PEPTIDOGLYCAN;

ANIMAL; ARTHRITIS; ARTICLE; BACTERIAL INFECTION; CELL WALL; DISEASE MODEL; DOG; IMMUNOLOGY; MICROBIOLOGY; RABBIT; RAT; RHEUMATOID ARTHRITIS; STREPTOCOCCUS; SWINE; SWINE DISEASE; SYNOVITIS;

ANIMAL; ARTHRITIS; ARTHRITIS, RHEUMATOID; CELL WALL; DISEASE MODELS, ANIMAL; DOGS; ERYSIPELOTHRIX INFECTIONS; FREUND'S ADJUVANT; PEPTIDOGLYCAN; RABBITS; RATS; STREPTOCOCCUS; SWINE; SWINE ERYSIPELAS; SYNOVITIS;

EID: 0016927869     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780190222     Document Type: Review

References (69)

1. The experimental production of arthritis. A review
2. Pathophysiology of rheumatoid arthritis
3. Rheumatoid arthritis of swine; a comparative pathologic study of clinical spontaneous remissions and exacerbations
4. Electrophoretic and serologic changes of blood serum of arthritic (rheumatoid) dogs infected with Erysipilothrix insidiosa
5. Immunologic studies of an experimental chronic arthritis resembling rheumatoid arthritis
6. Rabbit arthritis induced by cell‐free extracts of Erysipilothrix
7. Development of arthritis, periarthritis and periostitis in rats given adjuvants
8. Immunologic models used for the study of rheumatoid arthritis
9. Experimental joint disease. Observations on adjuvant‐induced arthritis
10. Adjuvant experimental polyarthritis
11. Differences in the severity of adjuvant arthritis in four strains of rats
12. Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis
13. The pathogenesis of adjuvant disease in the rat. I. A histologic study of early lesions in the joints and skin
14. Light and electron microscope studies in carragheenin, adjuvant, and tuberculin‐induced arthritis
15. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen
16. Passive transfer of adjuvant arthritis by lymph node or spleen cells
17. Passive transfer of adjuvant arthritis in rats with living lymphoid cells of sensitized donors
18. Bone marrow as a source of cells in reactions of cellular hypersensitivity. III. Adjuvant arthritis in the rat
19. Further immunologic studies of adjuvant disease in the rat
20. Adjuvant arthritis induced by Corynebacterium rubrum
21. Role of lymph nodes in adjuvant‐induced arthritis in rats
22. Prolongation of inflammation in rats inoculated with adjuvant
23. Protection of rats against adjuvant arthritis by bacterial lipopolysaccharides
24. Adjuvant arthritis in the rat. Effect of intraperitoneal injections of either whole dead mycobacteria or tuberculin
25. Inhibition of adjuvant arthritis by protein antigens. I. Inhibitory capacities and dose relationships of different proteins
26. Selective and specific inhibition of 24 hour skin reactions in the guinea pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy
27. The mechanism of immunological unresponsiveness to picryl chloride and the possible role of antibody mediated depression
28. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats
29. Isolation and properties of a macromolecular, water‐soluble, immuno‐adjuvant fraction from the cell wall of Mycobacterium smegmatis
30. Water‐soluble and lipid‐free fraction from BCG with adjuvant and antitumour activity
31. 14‐labeled mycobacteria in adjuvant‐induced polyarthritis
32. Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A‐variant streptococci
33. The immunochemistry of peptidoglycan. I. The immunodominant site of the peptide subunit and the contribution of each of the amino acids to the binding properties of the peptides
34. The immunochemistry of peptidoglycan. Separation and characterization of antibodies to the glycan and to the peptide subunit
35. Rheumatoid factor properties of hyperimmune rabbit sera
36. Occurrence of 19S and 7S anti‐IgG's during hyperimmunization of rabbits with streptococci
37. Isolation and immunochemical characterization of rabbit 7S anti‐IgG with restricted heterogeneity
38. Homogeneous rabbit 7S anti‐IgG with antibody specificity for peptidoglycan
39. Streptococcal anti‐group A precipitins in sera from patients with rheumatic arthritis and acute glomerulonephritis
40. Relation of particle size of C polysaccharide complexes of group A streptococci to toxic effects on connective tissue
41. The effect of a toxic cellular component of Group A streptococci on connective tissue
42. Biological properties of streptococcal cell‐wall particles. I. Determinants of the chronic nodular lesion of connective tissue
43. Persistence of Group A streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue
44. Rheumatic‐like cardiac lesions in mice
45. Relation of rheumatic‐like cardiac lesions of the mouse to localization of Group A streptococcal cell walls
46. 14C‐labeled group A streptococci and micrococci in muscular lesions in the mouse
47. Association of experimental chronic arthritis with the persistence of Group A streptococcal cell walls in the articular tissue
48. Production of chronic arthritis in rats with Group A streptococcal cellular components
49. Relation of experimental arthritis in rats to localization of Group A streptococcal cell walls
50. Contact sensitivity in the mouse. IV. The role of lymphocytes and macrophages in passive transfer and the mechanism of their interaction
51. Macrophage‐lymphocyte synergy in the production of osteoclast activating factor
52. Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance
53. Synovitis of recent onset. A clinicopatholigc study during the first month of disease
54. Early joint lesions of rheumatoid arthritis
55. Pathogenic effects of inhaled particles and antigens
56. Participation of mononuclear phagocytes in chronic inflammatory diseases
57. Symposium on the rheumatoid synovial membrane. IV. Joint erosion in rheumatoid arthritis
58. Rheumatoid synovitis. An extravascular immune complex disease
59. A radioactive hapten‐binding assay for measuring antibodies to the pentapeptide determinant of peptidoglycan
60. Yersiniosis as an internal disease
61. HL‐A 27 in reactive arthritis: a study of Yersinia arthritis and Reiter's disease
62. The bentonite granuloma. Characterization of a model system for infectious and foreign body granulomatous inflammation using soluble mycobacterial, histoplasma and schistosoma antigens
63. Rheumatoid arthritis—etiologic considerations